Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Complementation Tests00:49

Complementation Tests

A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual disorder: does expert clinical experience support the rationale for cariprazine use?

European review for medical and pharmacological sciences·2024
Same author

Optimising plasma clozapine levels to improve treatment response: an individual patient data meta-analysis and receiver operating characteristic curve analysis.

The British journal of psychiatry : the journal of mental science·2023
Same author

Incidence of tick-borne spotted fever group Rickettsia species in rodents in two regions in Kazakhstan.

Scientific reports·2022
Same author

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.

Translational psychiatry·2022
Same author

[Radiological and functional results in high-energy tibial plate fractures].

Acta ortopedica mexicana·2022
Same author

The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment.

Endocrine-related cancer·2021

Related Experiment Video

Updated: Jul 15, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Complement 1 inhibitor is a regulator of the alternative complement pathway.

H Jiang1, E Wagner, H Zhang

  • 1Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA.

The Journal of Experimental Medicine
|December 6, 2001
PubMed
Summary

Complement 1 inhibitor (C1-INH) regulates the alternative complement pathway. This study shows C1-INH inhibits paroxysmal nocturnal hemoglobinuria (PNH) erythrocyte lysis by preventing factor B and C3 binding.

More Related Videos

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
07:20

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

Published on: May 19, 2020

Related Experiment Videos

Last Updated: Jul 15, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
07:20

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

Published on: May 19, 2020

Area of Science:

  • Immunology
  • Complement System Biology

Background:

  • The alternative complement pathway is a crucial part of innate immunity.
  • Dysregulation of the alternative pathway is implicated in various diseases.
  • Complement 1 inhibitor (C1-INH) is a known regulator of the classical and lectin pathways.

Purpose of the Study:

  • To investigate the role of C1-INH as an inhibitor of the alternative complement pathway.
  • To elucidate the molecular mechanisms by which C1-INH regulates the alternative pathway.

Main Methods:

  • Assessing C1-INH's effect on paroxysmal nocturnal hemoglobinuria (PNH) erythrocyte lysis in human serum.
  • Measuring the binding of factors B and C3 to erythrocytes.
  • Investigating C1-INH interaction with C3b and cobra venom factor (CVF) using immobilized assays.
  • Analyzing the effect of C1-INH on factor D-mediated cleavage of factor B.
  • Evaluating alternative pathway lysis upon C1-INH removal from serum.

Main Results:

  • C1-INH prevented alternative pathway-induced lysis of PNH erythrocytes.
  • C1-INH inhibited the binding of factors B and C3 to erythrocytes.
  • C1-INH bound to C3b and CVF, preventing factor B interaction with these components.
  • C1-INH inhibited factor D-mediated cleavage of factor B and subsequent C3 cleavage.
  • Removal of C1-INH significantly increased alternative pathway lysis.

Conclusions:

  • C1-INH acts as a physiological downregulator of the alternative complement pathway convertase.
  • C1-INH inhibits the alternative pathway by interfering with factor B binding to C3b.
  • These findings highlight C1-INH's potential therapeutic role in alternative pathway-mediated diseases.